Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.

Completed

Conditions studied: Respiratory Depression, Respiratory Insufficiency

In brief

Single site prospective observational nested study of bedside CS20p monitor on the GCF impeded into a retrospective review of the frequency of escalation of care with intermittent vitals signs compared to continuous respiratory monitoring.

Key facts

Study ID

NCT03050983

Run by

Medtronic - MITG

People needed

440

Starts

2017-02-15

Expected to finish

2020-09-10

Last updated by the study team

2020-09-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Spontaneous breathing adults ≥ 18 years of age, both male and female
• On dual parameter CS20p monitoring with both capnography and pulse oximetry per Vanderbilt standard of care to monitor patients for respiratory compromise.
• Expected minimum duration of 24 hours of continued capnography and pulse oximetry monitoring.

You may not qualify if…

• Those patients who are expected to be discharged within six hours on the randomly selected observation floor.
• Those patients not on the randomly selected floor for observation.
• Those subjects randomly removed from the selected floor for observation pool in order to limit the number of subjects to be observed.
• Those subjects in rooms with limited Wi-Fi signal quality as per VUMC IT.

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.